{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T04:12:04Z","timestamp":1770091924695,"version":"3.49.0"},"reference-count":70,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T00:00:00Z","timestamp":1759795200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The fight against leprosy has entered the crucial final phase in India, with the government\u2019s announcement of a national plan for zero transmission by 2027. Presently, leprosy has pockets of high prevalence in India and unknown transmission chains. At this juncture, we focus on essential aspects of this disease to help everyone understand the basics of the causative agent, disease prognosis, epidemiology, disease-associated societal implications and prevention strategies. Our endeavour aims to inspire novel concepts among early career researchers for combating leprosy.<\/jats:p>","DOI":"10.1093\/trstmh\/traf107","type":"journal-article","created":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T11:32:48Z","timestamp":1757935968000},"page":"87-94","source":"Crossref","is-referenced-by-count":0,"title":["Leprosy in India: challenges, advances and the path to eradication"],"prefix":"10.1093","volume":"120","author":[{"given":"Sayanti","family":"Chatterjee","sequence":"first","affiliation":[{"name":"Amity Institute of Biotechnology, Amity University Kolkata , Action area II, Rajarhat Newtown, Kolkata 700135 West Bengal ,","place":["India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pragya","family":"Santra","sequence":"additional","affiliation":[{"name":"Amity Institute of Biotechnology, Amity University Kolkata , Action area II, Rajarhat Newtown, Kolkata 700135 West Bengal ,","place":["India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riddhi","family":"Paul","sequence":"additional","affiliation":[{"name":"Amity Institute of Biotechnology, Amity University Kolkata , Action area II, Rajarhat Newtown, Kolkata 700135 West Bengal ,","place":["India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asesh","family":"Banerjee","sequence":"additional","affiliation":[{"name":"Amity Institute of Biotechnology, Amity University Kolkata , Action area II, Rajarhat Newtown, Kolkata 700135 West Bengal ,","place":["India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1009-2781","authenticated-orcid":false,"given":"Prabuddha","family":"Gupta","sequence":"additional","affiliation":[{"name":"Amity Institute of Biotechnology, Amity University Kolkata , Action area II, Rajarhat Newtown, Kolkata 700135 West Bengal ,","place":["India"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,10,7]]},"reference":[{"issue":"1","key":"2026020210311669400_bib1","doi-asserted-by":"crossref","first-page":"65","DOI":"10.47276\/lr.84.1.65","article-title":"Clinical characteristics and outcome in multibacillary (MB) leprosy patients treated with 12 months WHO MDT-MBR: a retrospective analysis of 730 patients from a leprosy clinic at a tertiary care hospital of Northern India","volume":"84","author":"Dogra","year":"2013","journal-title":"Lepr Rev"},{"issue":"1","key":"2026020210311669400_bib2","first-page":"35","article-title":"Determinants of patients\u2019 delay with disability in the diagnosed leprosy cases in the three major states of India: a case-control study","volume":"89","author":"Govindarajulu","year":"2022","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"1","key":"2026020210311669400_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4103\/ijmr.ijmr_64_24","article-title":"Eradication of leprosy from India: reflections on past, present & future","volume":"159","author":"Katoch","year":"2024","journal-title":"Indian J Med Res"},{"issue":"2","key":"2026020210311669400_bib4","doi-asserted-by":"crossref","first-page":"145","DOI":"10.47276\/lr.91.2.145","article-title":"Accelerating towards a leprosy free India through innovative approaches in the National Leprosy Eradication Programme (NLEP), India","volume":"91","author":"Kumar","year":"2020","journal-title":"Lepr Rev"},{"issue":"9","key":"2026020210311669400_bib5","doi-asserted-by":"crossref","first-page":"e0010756","DOI":"10.1371\/journal.pntd.0010756","article-title":"Delayed detection of leprosy cases: a systematic review of healthcare-related factors","volume":"16","author":"Dharmawan","year":"2022","journal-title":"PLoS Negl Trop Dis"},{"issue":"2","key":"2026020210311669400_bib6","doi-asserted-by":"crossref","first-page":"167","DOI":"10.4103\/cdr.cdr_118_23","article-title":"Zero leprosy strategic plans: global and national level: a short communication","volume":"8","author":"Geetha","year":"2024","journal-title":"Clin Dermatol Rev"},{"key":"2026020210311669400_bib7","volume-title":"National Strategic Plan and Roadmap for Leprosy 2023\u20132027","author":"National Leprosy Eradication Programme","year":"2023"},{"issue":"1","key":"2026020210311669400_bib8","doi-asserted-by":"crossref","first-page":"11","DOI":"10.18231\/j.ijfcm.2024.003","article-title":"Challenges of sustaining leprosy elimination in India and prospects of eradication: current status & way forwards","volume":"11","author":"Khan","year":"2024","journal-title":"Indian J Forensic Community Med"},{"issue":"4","key":"2026020210311669400_bib9","first-page":"189","article-title":"Leprosy beyond MDT: study of follow-up of 100 released from treatment cases","volume":"82","author":"Vara","year":"2010","journal-title":"Indian J Lepr"},{"issue":"1","key":"2026020210311669400_bib10","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1080\/21505594.2022.2141987","article-title":"Pathogenicity and virulence of Mycobacterium leprae","volume":"13","author":"Sugawara-Mikami","year":"2022","journal-title":"Virulence"},{"key":"2026020210311669400_bib11","article-title":"Leprosy","author":"Bhandari","year":"2025"},{"issue":"1","key":"2026020210311669400_bib12","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1489\/1544-581X(2004)072<0016:ITOMBI>2.0.CO;2","article-title":"IL-10 treatment of macrophages bolsters intracellular survival of Mycobacterium leprae","volume":"72","author":"Fukutomi","year":"2004","journal-title":"Int J Lepr Mycobact Dis"},{"issue":"6","key":"2026020210311669400_bib13","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1309\/AJCPP72FJZZRRVMM","article-title":"A new Mycobacterium species causing diffuse lepromatous leprosy","volume":"130","author":"Han","year":"2008","journal-title":"Am J Clin Pathol"},{"issue":"1","key":"2026020210311669400_bib14","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2217\/fmb.10.153","article-title":"Mycobacterium leprae: genes, pseudogenes and genetic diversity","volume":"6","author":"Singh","year":"2011","journal-title":"Future Microbiol"},{"issue":"2","key":"2026020210311669400_bib15","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/j.1574-6968.2006.00276.x","article-title":"High-level expression of pseudogenes in Mycobacterium leprae","volume":"259","author":"Suzuki","year":"2006","journal-title":"FEMS Microbiol Lett"},{"issue":"2","key":"2026020210311669400_bib16","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1590\/abd1806-4841.20142450","article-title":"Leprosy: review of the epidemiological, clinical, and etiopathogenic aspects \u2013 part 1","volume":"89","author":"Last\u00f3ria","year":"2014","journal-title":"An Bras Dermatol"},{"issue":"5","key":"2026020210311669400_bib17","first-page":"e59464","article-title":"Leprosy in post-elimination era: a study conducted in rural tertiary settings in North India","volume":"16","author":"Kumar","year":"2024","journal-title":"Cureus"},{"key":"2026020210311669400_bib18","doi-asserted-by":"crossref","first-page":"105041","DOI":"10.1016\/j.actatropica.2019.105041","article-title":"Mycobacterium leprae\u2019s evolution and environmental adaptation","volume":"197","author":"Chavarro-Portillo","year":"2019","journal-title":"Acta Trop"},{"issue":"12","key":"2026020210311669400_bib19","doi-asserted-by":"crossref","first-page":"e0010972","DOI":"10.1371\/journal.pntd.0010972","article-title":"Identifying clusters of leprosy patients in India: a comparison of methods","volume":"16","author":"Taal","year":"2022","journal-title":"PLoS Negl Trop Dis"},{"issue":"2","key":"2026020210311669400_bib20","first-page":"79","article-title":"Is soil an alternative source of leprosy infection?","volume":"12","author":"Chakrabarty","year":"2001","journal-title":"Acta Leprol"},{"issue":"2","key":"2026020210311669400_bib21","doi-asserted-by":"crossref","first-page":"142","DOI":"10.47276\/lr.86.2.142","article-title":"Current knowledge on Mycobacterium leprae transmission: a systematic literature review","volume":"86","author":"Bratschi","year":"2015","journal-title":"Lepr Rev"},{"issue":"1","key":"2026020210311669400_bib22","first-page":"12","article-title":"Indeterminate leprosy: histopathologic and histochemical predictive parameters involved in its possible change to paucibacillary or multibacillary leprosy","volume":"59","author":"Takahashi","year":"1991","journal-title":"Int J Lepr Mycobact Dis"},{"issue":"3","key":"2026020210311669400_bib23","first-page":"255","article-title":"Classification of leprosy according to immunity. A five-group system","volume":"34","author":"Ridley","year":"1966","journal-title":"Int J Lepr Mycobact Dis"},{"issue":"3","key":"2026020210311669400_bib24","doi-asserted-by":"crossref","first-page":"252","DOI":"10.4103\/0378-6323.179086","article-title":"Pure neuritic leprosy: current status and relevance","volume":"82","author":"Rao","year":"2016","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"3","key":"2026020210311669400_bib25","first-page":"433","article-title":"Clinical and histopathological correlation in the classification of leprosy","volume":"61","author":"Bhatia","year":"1993","journal-title":"Int J Lepr Mycobact Dis"},{"issue":"9","key":"2026020210311669400_bib26","first-page":"e44767","article-title":"Leprosy classification, clinical features, epidemiology, and host immunological responses: failure of eradication in 2023","volume":"15","author":"Alrehaili","year":"2023","journal-title":"Cureus"},{"issue":"12","key":"2026020210311669400_bib27","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1111\/j.1365-4632.2011.04994.x","article-title":"Diagnosing leprosy: revisiting the role of the slit-skin smear with critical analysis of the applicability of polymerase chain reaction in diagnosis","volume":"50","author":"Banerjee","year":"2011","journal-title":"Int J Dermatol"},{"issue":"1","key":"2026020210311669400_bib28","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3390\/proteomes9010007","article-title":"Insights into Mycobacterium leprae proteomics and biomarkers\u2014an overview","volume":"9","author":"Gautam","year":"2021","journal-title":"Proteomes"},{"issue":"1","key":"2026020210311669400_bib29","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s40249-024-01262-9","article-title":"Rapid test for Mycobacterium leprae infection: a practical tool for leprosy","volume":"13","author":"Pierneef","year":"2024","journal-title":"Infect Dis Poverty"},{"issue":"2","key":"2026020210311669400_bib30","first-page":"429","article-title":"Mycobacterium leprae infection of human Schwann cells depends on selective host kinases and pathogen-modulated endocytic pathways","volume":"238","author":"Alves","year":"2004","journal-title":"FEMS Microbiol Lett"},{"issue":"3","key":"2026020210311669400_bib31","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s00281-020-00790-4","article-title":"The immunology of other mycobacteria: M. ulcerans, M. leprae","volume":"42","author":"R\u00f6ltgen","year":"2020","journal-title":"Semin Immunopathol"},{"issue":"2","key":"2026020210311669400_bib32","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1462-5822.2010.01533.x","article-title":"Modulation of lipid droplets by Mycobacterium leprae in Schwann cells: a putative mechanism for host lipid acquisition and bacterial survival in phagosomes","volume":"13","author":"Mattos","year":"2011","journal-title":"Cell Microbiol"},{"issue":"11","key":"2026020210311669400_bib33","first-page":"e49155","article-title":"Immunopathogenesis of type 1 and type 2 leprosy reaction: an update review","volume":"15","author":"Dewi","year":"2023","journal-title":"Cureus"},{"issue":"3","key":"2026020210311669400_bib34","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1586\/1744666X.2015.1012501","article-title":"Type 1 reaction in leprosy: a model for a better understanding of tissue immunity under an immunopathological condition","volume":"11","author":"Andrade","year":"2015","journal-title":"Expert Rev Clin Immunol"},{"key":"2026020210311669400_bib35","doi-asserted-by":"crossref","first-page":"233","DOI":"10.3389\/fimmu.2017.00233","article-title":"A systematic review of immunological studies of erythema nodosum leprosum","volume":"8","author":"Polycarpou","year":"2017","journal-title":"Front Immunol"},{"key":"2026020210311669400_bib36","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.3389\/fimmu.2018.01674","article-title":"Genetic susceptibility to leprosy\u2014from classic immune-related candidate genes to hypothesis-free, whole genome approaches","volume":"9","author":"Cambri","year":"2018","journal-title":"Front Immunol"},{"key":"2026020210311669400_bib37","doi-asserted-by":"crossref","first-page":"698588","DOI":"10.3389\/fmicb.2021.698588","article-title":"Mycobacterium lepromatosis as a second agent of Hansen\u2019s disease","volume":"12","author":"Deps","year":"2021","journal-title":"Front Microbiol"},{"key":"2026020210311669400_bib38","volume-title":"A twin study on leprosy.","author":"Chakravartti","year":"1973"},{"issue":"2","key":"2026020210311669400_bib39","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/cge.13376","article-title":"Discovery of 4 exonic and 1 intergenic novel susceptibility loci for leprosy","volume":"94","author":"Wang","year":"2018","journal-title":"Clin Genet"},{"issue":"2","key":"2026020210311669400_bib40","first-page":"98","article-title":"Production of host-protective (IFN-gamma), host-impairing (IL-10, IL-13) and inflammatory (TNF-alpha) cytokines by PBMC from leprosy patients stimulated with mycobacterial antigens","volume":"8","author":"Machado","year":"1998","journal-title":"Eur J Dermatol"},{"issue":"4","key":"2026020210311669400_bib41","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1590\/0074-02760160366","article-title":"Polymorphisms in genes TLR1, 2 and 4 are associated with differential cytokine and chemokine serum production in patients with leprosy","volume":"112","author":"Santana","year":"2017","journal-title":"Mem Inst Oswaldo Cruz"},{"issue":"Suppl 1","key":"2026020210311669400_bib42","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1590\/S0074-02762012000900020","article-title":"Genetics of leprosy reactions: an overview","volume":"107","author":"Fava","year":"2012","journal-title":"Mem Inst Oswaldo Cruz"},{"issue":"7","key":"2026020210311669400_bib43","doi-asserted-by":"crossref","first-page":"e1000979","DOI":"10.1371\/journal.ppat.1000979","article-title":"Leprosy and the adaptation of human toll-like receptor 1","volume":"6","author":"Wong","year":"2010","journal-title":"PLoS Pathog"},{"issue":"10","key":"2026020210311669400_bib44","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1001\/jamadermatol.2019.1768","article-title":"Risk factors for physical disability in patients with leprosy: a systematic review and meta-analysis","volume":"155","author":"De Paula","year":"2019","journal-title":"JAMA Dermatol"},{"issue":"6","key":"2026020210311669400_bib45","doi-asserted-by":"crossref","first-page":"e0007495","DOI":"10.1371\/journal.pntd.0007495","article-title":"Risk of disability among adult leprosy cases and determinants of delay in diagnosis in five states of India: a case-control study","volume":"13","author":"Srinivas","year":"2019","journal-title":"PLoS Negl Trop Dis"},{"issue":"2","key":"2026020210311669400_bib46","doi-asserted-by":"crossref","first-page":"83","DOI":"10.4103\/idoj.IDOJ_282_17","article-title":"Current situation of leprosy in India and its future implications","volume":"9","author":"Rao","year":"2018","journal-title":"Indian Dermatol Online J"},{"issue":"2","key":"2026020210311669400_bib47","doi-asserted-by":"crossref","first-page":"131","DOI":"10.4103\/ijdvl.IJDVL_1070_16","article-title":"Elimination of leprosy in India: an analysis","volume":"84","author":"Sengupta","year":"2018","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"2","key":"2026020210311669400_bib48","doi-asserted-by":"crossref","first-page":"218","DOI":"10.4103\/ijmr.ijmr_3247_21","article-title":"Epidemiological scenario of leprosy in marginalized communities of India: focus on scheduled tribes","volume":"156","author":"Sharma","year":"2022","journal-title":"Indian J Med Res"},{"issue":"6","key":"2026020210311669400_bib49","doi-asserted-by":"crossref","first-page":"723\u2013","DOI":"10.4103\/ijd.ijd_370_23","article-title":"Clinico-epidemiological trends of leprosy at a tertiary care centre of South Rajasthan: a 10-year retrospective study","volume":"68","author":"Masatkar","year":"2023","journal-title":"Indian J Dermatol"},{"issue":"2","key":"2026020210311669400_bib50","doi-asserted-by":"crossref","first-page":"93","DOI":"10.4103\/0019-5154.108029","article-title":"Fixed-duration therapy in leprosy: limitations and opportunities","volume":"58","author":"Malathi","year":"2013","journal-title":"Indian J Dermatol"},{"key":"2026020210311669400_bib51","article-title":"Treatment of leprosy","volume-title":"The international textbook of leprosy","author":"Lockwood","year":"2016","edition":"1st ed."},{"issue":"1","key":"2026020210311669400_bib52","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/s41572-024-00575-1","article-title":"Leprosy","volume":"10","author":"Grijsen","year":"2024","journal-title":"Nat Rev Dis Primer"},{"issue":"3","key":"2026020210311669400_bib53","doi-asserted-by":"crossref","first-page":"547","DOI":"10.4269\/ajtmh.19-0390","article-title":"Evidence for Mycobacterium leprae drug resistance in a large cohort of leprous neuropathy patients from India","volume":"102","author":"Mahajan","year":"2020","journal-title":"Am J Trop Med Hyg"},{"key":"2026020210311669400_bib54","volume-title":"Guidelines for the diagnosis, treatment and prevention of leprosy","author":"World Health Organization Regional Office for South-East Asia","year":"2018"},{"key":"2026020210311669400_bib55","first-page":"100495","article-title":"Computational investigation of the global prevalence of multidrug resistant Mycobacterium leprae: a systematic review and meta-analysis","volume":"37","author":"Zivarifar","year":"2024","journal-title":"J Clin Tuberc Mycobact Dis"},{"issue":"12","key":"2026020210311669400_bib56","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1111\/j.1365-3156.2011.02873.x","article-title":"Is there a role for rifampicin, ofloxacin and minocycline (ROM) therapy in the treatment of leprosy? Systematic review and meta-analysis","volume":"16","author":"Setia","year":"2011","journal-title":"Trop Med Int Health"},{"issue":"10","key":"2026020210311669400_bib57","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.2174\/1386207325666211007110638","article-title":"Repurposing drugs to combat drug resistance in leprosy: a review of opportunities","volume":"25","author":"Sharma","year":"2022","journal-title":"Comb Chem High Throughput Screen"},{"issue":"3&4","key":"2026020210311669400_bib58","doi-asserted-by":"crossref","first-page":"293","DOI":"10.25259\/IJMR_1289_2024","article-title":"Efficacy of leprosy vaccines across the globe: a systematic review & meta-analysis of randomized controlled trials","volume":"160","author":"Dasgupta","year":"2024","journal-title":"Indian J Med Res"},{"key":"2026020210311669400_bib59","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/978-3-031-24355-4_4","article-title":"Leprosy vaccines: developments for prevention and treatment","volume-title":"Vaccines for neglected pathogens: strategies, achievements and challenges","author":"Wang","year":"2023"},{"issue":"6","key":"2026020210311669400_bib60","doi-asserted-by":"crossref","first-page":"753","DOI":"10.4103\/idoj.idoj_360_23","article-title":"Mycobacterium indicus pranii (MIP) vaccine: pharmacology, indication, dosing schedules, administration, and side effects in clinical practice","volume":"14","author":"Dogra","year":"2023","journal-title":"Indian Dermatol Online J"},{"issue":"7647","key":"2026020210311669400_bib61","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1136\/bmj.39500.885752.BE","article-title":"Effectiveness of single dose rifampicin in preventing leprosy in close contacts of patients with newly diagnosed leprosy: cluster randomised controlled trial","volume":"336","author":"Moet","year":"2008","journal-title":"BMJ"},{"issue":"1","key":"2026020210311669400_bib62","doi-asserted-by":"crossref","first-page":"e81","DOI":"10.1016\/S2214-109X(20)30396-X","article-title":"Leprosy post-exposure prophylaxis with single-dose rifampicin (LPEP): an international feasibility programme","volume":"9","author":"Richardus","year":"2021","journal-title":"Lancet Glob Health"},{"key":"2026020210311669400_bib63","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1186\/s12879-018-3402-4","article-title":"An enhanced regimen as post-exposure chemoprophylaxis for leprosy: PEP++","volume":"18","author":"Mieras","year":"2018","journal-title":"BMC Infect Dis"},{"issue":"1","key":"2026020210311669400_bib64","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1128\/CMR.00079-13","article-title":"Leprosy in the 21st century","volume":"28","author":"White","year":"2015","journal-title":"Clin Microbiol Rev"},{"issue":"4","key":"2026020210311669400_bib65","doi-asserted-by":"crossref","first-page":"292","DOI":"10.47276\/lr.93.4.292","article-title":"Improving early case detection in leprosy: reports from recent workshops","volume":"93","author":"Saunderson","year":"2022","journal-title":"Lepr Rev"},{"key":"2026020210311669400_bib66","first-page":"100192","article-title":"Reimagining leprosy elimination with AI analysis of a combination of skin lesion images with demographic and clinical data","volume":"9","author":"Barbieri","year":"2022","journal-title":"Lancet Reg Health Am"},{"issue":"4","key":"2026020210311669400_bib67","doi-asserted-by":"crossref","first-page":"307","DOI":"10.47276\/lr.86.4.307","article-title":"Leprosy: a review on elimination, reducing the disease burden, and future research","volume":"86","author":"Chaptini","year":"2015","journal-title":"Lepr Rev"},{"key":"2026020210311669400_bib68","doi-asserted-by":"publisher","DOI":"10.20935\/AL3827","article-title":"The linkage between poverty and leprosy","author":"Siyoto","year":"2021","journal-title":"Acad Lett"},{"issue":"4","key":"2026020210311669400_bib69","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1093\/ije\/dyl072","article-title":"Socioeconomic, environmental, and behavioural risk factors for leprosy in North-east Brazil: results of a case\u2013control study","volume":"35","author":"Kerr-Pontes","year":"2006","journal-title":"Int J Epidemiol"},{"issue":"1","key":"2026020210311669400_bib70","doi-asserted-by":"crossref","first-page":"1","DOI":"10.25259\/IJMR_2212_2024","article-title":"Beating leprosy: unmasking challenges, ending stigma, & prioritizing mental well-being","volume":"161","author":"Singh","year":"2025","journal-title":"Indian J Med Res"}],"container-title":["Transactions of The Royal Society of Tropical Medicine and Hygiene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/trstmh\/article-pdf\/120\/2\/87\/64526218\/traf107.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/trstmh\/article-pdf\/120\/2\/87\/64526218\/traf107.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T15:34:52Z","timestamp":1770046492000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/trstmh\/article\/120\/2\/87\/8276505"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,7]]},"references-count":70,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,10,7]]},"published-print":{"date-parts":[[2026,2,2]]}},"URL":"https:\/\/doi.org\/10.1093\/trstmh\/traf107","relation":{},"ISSN":["0035-9203","1878-3503"],"issn-type":[{"value":"0035-9203","type":"print"},{"value":"1878-3503","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,2]]},"published":{"date-parts":[[2025,10,7]]}}}